SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5u3n'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ICT_D_T44D129_2
(TRANSTHYRETIN)		 5u3n DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens) 		4 / 7 LEU L 135
THR L 172
SER L 162
THR L 164
 None
 0.77A 1ictD-5u3nL:
undetectable		 1ictD-5u3nL:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_A_THHA3001_1
(AMINOMETHYLTRANSFERA
SE)		 5u3n DH511.12P FAB HEAVY
CHAIN
DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens;
Homo
sapiens) 		3 / 3 ASP H  53
GLU H  96
TYR L  96
 None
 0.77A 1wsvA-5u3nH:
undetectable		 1wsvA-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AOJ_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 5u3n DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens) 		4 / 5 LEU L 179
GLY L 128
PRO L 120
VAL L 132
 None
 0.83A 2aojA-5u3nL:
undetectable		 2aojA-5u3nL:
16.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OLD_B_IPHB2001_0
(BENCE JONES KWR
PROTEIN -
IMMUNOGLOBULIN LIGHT
CHAIN)		 5u3n DH511.12P FAB HEAVY
CHAIN
DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens;
Homo
sapiens) 		4 / 7 TYR H  91
TYR L  36
PRO L  44
TYR L  87
 None
 0.51A 2oldA-5u3nH:
14.2
2oldB-5u3nH:
17.0		 2oldA-5u3nH:
31.56
2oldB-5u3nH:
31.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OLD_B_IPHB2001_0
(BENCE JONES KWR
PROTEIN -
IMMUNOGLOBULIN LIGHT
CHAIN)		 5u3n DH511.12P FAB HEAVY
CHAIN
DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens;
Homo
sapiens) 		5 / 7 TYR L  36
HIS L  38
PRO L  44
TYR L  87
TYR H  91
 None
 0.45A 2oldA-5u3nL:
21.5
2oldB-5u3nL:
19.3		 2oldA-5u3nL:
43.69
2oldB-5u3nL:
43.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OMB_D_IPHD2002_0
(BENCE JONES KWR
PROTEIN -
IMMUNOGLOBULIN LIGHT
CHAIN)		 5u3n DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens) 		4 / 7 TYR L  36
HIS L  38
PRO L  44
TYR L  87
 None
 0.36A 2ombC-5u3nL:
20.9
2ombD-5u3nL:
19.1		 2ombC-5u3nL:
43.69
2ombD-5u3nL:
43.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OMB_D_IPHD2002_0
(BENCE JONES KWR
PROTEIN -
IMMUNOGLOBULIN LIGHT
CHAIN)		 5u3n DH511.12P FAB HEAVY
CHAIN
DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens;
Homo
sapiens) 		4 / 7 TYR L  36
HIS L  38
PRO L  44
TYR H  91
 None
 0.71A 2ombC-5u3nL:
20.9
2ombD-5u3nL:
19.1		 2ombC-5u3nL:
43.69
2ombD-5u3nL:
43.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HUO_A_PNNA302_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		4 / 6 LEU H 189
GLY H 190
ALA H 125
PRO H 126
 None
 0.44A 3huoA-5u3nH:
undetectable		 3huoA-5u3nH:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R9T_B_BEZB264_0
(ECHA1_1)		 5u3n DH511.12P FAB HEAVY
CHAIN
DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens;
Homo
sapiens) 		4 / 7 ILE L  97
GLU H  46
ALA H  60
ALA H  61
 None
 0.91A 3r9tB-5u3nL:
undetectable		 3r9tB-5u3nL:
23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EM2_A_SALA501_1
(UNCHARACTERIZED
HTH-TYPE
TRANSCRIPTIONAL
REGULATOR SAR2349)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		4 / 5 TYR H  90
LEU H  80
LEU H  82
ARG H  66
 None
 1.19A 4em2A-5u3nH:
undetectable		 4em2A-5u3nH:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.84A 4qvnH-5u3nH:
undetectable
4qvnI-5u3nH:
undetectable		 4qvnH-5u3nH:
21.84
4qvnI-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 10 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.84A 4qvnV-5u3nH:
undetectable
4qvnW-5u3nH:
undetectable		 4qvnV-5u3nH:
21.84
4qvnW-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.82A 4qvpH-5u3nH:
undetectable
4qvpI-5u3nH:
undetectable		 4qvpH-5u3nH:
21.84
4qvpI-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.81A 4qvpV-5u3nH:
undetectable
4qvpW-5u3nH:
undetectable		 4qvpV-5u3nH:
21.84
4qvpW-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.83A 4qvqH-5u3nH:
undetectable
4qvqI-5u3nH:
undetectable		 4qvqH-5u3nH:
21.84
4qvqI-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.83A 4qvqV-5u3nH:
undetectable
4qvqW-5u3nH:
undetectable		 4qvqV-5u3nH:
21.84
4qvqW-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.88A 4qvvH-5u3nH:
undetectable		 4qvvH-5u3nH:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.88A 4qvvV-5u3nH:
undetectable		 4qvvV-5u3nH:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.88A 4qvyH-5u3nH:
undetectable		 4qvyH-5u3nH:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.89A 4qvyV-5u3nH:
undetectable
4qvyW-5u3nH:
undetectable		 4qvyV-5u3nH:
21.84
4qvyW-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 4qw0H-5u3nH:
undetectable
4qw0I-5u3nH:
undetectable		 4qw0H-5u3nH:
21.84
4qw0I-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 4qw0V-5u3nH:
undetectable
4qw0W-5u3nH:
undetectable		 4qw0V-5u3nH:
21.84
4qw0W-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.86A 4qw1H-5u3nH:
undetectable
4qw1I-5u3nH:
undetectable		 4qw1H-5u3nH:
21.84
4qw1I-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 4qw1V-5u3nH:
undetectable
4qw1W-5u3nH:
undetectable		 4qw1V-5u3nH:
21.84
4qw1W-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.87A 5bxnH-5u3nH:
undetectable
5bxnI-5u3nH:
undetectable		 5bxnH-5u3nH:
23.08
5bxnI-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZ7_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.85A 5cz7V-5u3nH:
undetectable
5cz7W-5u3nH:
undetectable		 5cz7V-5u3nH:
21.84
5cz7W-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 11 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.86A 5d0xV-5u3nH:
undetectable		 5d0xV-5u3nH:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L4E_D_EDPD402_1
(PROTON-GATED ION
CHANNEL)		 5u3n DH511.12P FAB LIGHT
CHAIN
(Homo
sapiens) 		4 / 8 THR L  74
SER L  63
THR L  72
SER L  65
 None
 1.00A 5l4eA-5u3nL:
undetectable
5l4eB-5u3nL:
undetectable
5l4eC-5u3nL:
undetectable
5l4eD-5u3nL:
3.3
5l4eE-5u3nL:
undetectable		 5l4eA-5u3nL:
22.54
5l4eB-5u3nL:
22.54
5l4eC-5u3nL:
22.54
5l4eD-5u3nL:
22.54
5l4eE-5u3nL:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.82A 5l5fH-5u3nH:
undetectable
5l5fI-5u3nH:
undetectable		 5l5fH-5u3nH:
21.84
5l5fI-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		5 / 12 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
 None
 0.83A 5l5fV-5u3nH:
undetectable
5l5fW-5u3nH:
undetectable		 5l5fV-5u3nH:
21.84
5l5fW-5u3nH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A94_B_ZOTB3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 5u3n DH511.12P FAB HEAVY
CHAIN
(Homo
sapiens) 		6 / 12 VAL H 184
THR H 135
LEU H 159
VAL H 163
GLY H 162
VAL H 211
 None
 1.50A 6a94B-5u3nH:
undetectable		 6a94B-5u3nH:
20.83